T. Rowe Price Growth ETF (TGRT) Chart & Stock Price History → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free TGRT Stock Alerts $31.52 +0.60 (+1.94%) (As of 04/26/2024 ET) Add Compare Share Share ChartStock AnalysisChartHoldingsRatingsStock AnalysisChartHoldingsRatings T. Rowe Price Growth ETF Stock Price Performance5 Day Performance+2.77%1 Month Performance-2.57%3 Month Performance+5.10%6 Month Performance+29.50%Year-To-Date Performance+10.48% Receive TGRT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for T. Rowe Price Growth ETF and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> TGRT Stock Chart for Saturday, April, 27, 2024 TGRT Chart by TradingView T. Rowe Price Growth ETF Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/26/2024$30.92$31.52+1.94%$31.57$31.52558 shs$75.65 million04/25/2024$31.13$30.92-0.67%$30.94$30.4912,122 shs$74.21 million04/24/2024$31.24$31.13-0.35%$31.48$31.0820,650 shs$74.71 million04/23/2024$30.67$31.24+1.86%$31.28$31.1910,254 shs$74.98 million04/22/2024$30.42$30.67+0.82%$30.67$30.471,647 shs$73.61 million04/19/2024$31.06$30.42-2.06%$30.96$30.352,907 shs$16.73 million Get the Latest News and Ratings for TGRT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for T. Rowe Price Growth ETF and its competitors with MarketBeat's FREE daily newsletter. 04/18/2024$31.25$31.06-0.61%$31.11$31.06963 shs$17.08 million04/17/2024$31.57$31.25-1.01%$31.70$31.252,663 shs$17.19 million04/16/2024$31.46$31.57+0.35%$31.67$31.566,492 shs$17.36 million04/15/2024$31.96$31.46-1.56%$32.31$31.4510,164 shs$17.30 million04/12/2024$32.43$31.96-1.45%$31.97$31.873,208 shs$17.58 million04/11/2024$32.02$32.43+1.28%$32.49$31.982,686 shs$17.84 million04/10/2024$32.20$32.02-0.56%$32.06$31.984,838 shs$17.61 million04/09/2024$32.21$32.20-0.02%$32.33$31.959,584 shs$17.71 million04/08/2024$32.27$32.21-0.19%$32.36$32.213,649 shs$17.71 million04/05/2024$31.76$32.27+1.61%$32.34$31.957,843 shs$17.75 million04/04/2024$32.17$31.76-1.27%$32.51$31.766,801 shs$17.47 million04/03/2024$32.07$32.17+0.31%$32.29$32.155,557 shs$17.69 million04/02/2024$32.33$32.07-0.80%$32.08$31.8823,527 shs$17.64 million04/01/2024$32.33$32.33$32.50$32.2111,674 shs$17.78 million03/29/2024$32.33$32.33$32.36$32.289,323 shs$17.78 million03/28/2024$32.35$32.33-0.06%$32.36$32.289,323 shs$17.78 million03/27/2024$32.34$32.35+0.03%$32.35$32.177,820 shs$17.79 million03/26/2024$32.44$32.34-0.31%$32.61$32.331,778 shs$17.79 million03/25/2024$32.60$32.44-0.49%$32.50$32.44830 shs$17.84 million03/22/2024$32.56$32.60+0.12%$32.65$32.501,441 shs$17.93 million03/21/2024$32.43$32.56+0.40%$32.67$32.525,779 shs$17.91 million03/20/2024$32.14$32.43+0.90%$32.43$32.247,425 shs$17.84 million03/19/2024$31.93$32.14+0.66%$32.14$31.768,447 shs$17.68 million03/18/2024$31.66$31.93+0.85%$32.14$31.904,213 shs$17.56 million03/15/2024$32.05$31.66-1.22%$31.78$31.642,036 shs$17.41 million03/14/2024$32.02$32.05+0.09%$32.05$31.87931 shs$17.63 million03/13/2024$32.13$32.02-0.34%$32.11$31.956,217 shs$17.61 million03/12/2024$31.53$32.13+1.90%$32.13$31.73903 shs$17.67 million03/11/2024$31.73$31.53-0.63%$31.67$31.431,862 shs$17.34 million03/08/2024$32.05$31.73-1.00%$32.37$31.667,464 shs$17.45 million03/07/2024$31.58$32.05+1.49%$32.09$31.716,102 shs$17.63 million03/06/2024$31.41$31.58+0.54%$31.69$31.542,696 shs$17.37 million03/05/2024$31.97$31.41-1.75%$31.71$31.362,700 shs$17.28 million03/04/2024$32.04$31.97-0.21%$32.03$31.975,224 shs$17.58 millionBetter than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>>03/01/2024$31.74$32.04+0.95%$32.04$31.7535,575 shs$17.62 million02/29/2024$31.44$31.74+0.95%$31.74$31.66403 shs$17.46 million02/28/2024$31.60$31.44-0.51%$31.44$31.39655 shs$17.29 million02/27/2024$31.61$31.60-0.03%$31.61$31.50926 shs$17.38 million02/26/2024$31.71$31.61-0.33%$31.82$31.612,000 shs$17.39 million02/23/2024$31.74$31.71-0.09%$31.90$31.674,658 shs$17.44 million02/22/2024$30.74$31.74+3.25%$31.77$31.433,104 shs$17.46 million02/21/2024$30.77$30.74-0.10%$30.74$30.523,863 shs$16.91 million02/20/2024$31.14$30.77-1.19%$31.00$30.643,462 shs$16.92 million02/19/2024$31.14$31.14+0.00%$31.40$31.147,200 shs$17.13 million02/16/2024$31.33$31.14-0.61%$31.40$31.147,283 shs$17.13 million02/15/2024$31.32$31.33+0.03%$31.35$31.301,349 shs$17.23 million02/14/2024$30.90$31.32+1.36%$31.32$31.122,345 shs$17.23 million02/13/2024$31.33$30.90-1.37%$31.12$30.787,123 shs$17.00 million02/12/2024$31.51$31.33-0.57%$31.58$31.335,813 shs$17.23 million02/09/2024$31.19$31.51+1.03%$31.53$31.443,177 shs$17.33 million02/08/2024$31.14$31.19+0.18%$31.21$31.1214,580 shs$17.15 million02/07/2024$30.71$31.14+1.38%$31.17$30.912,269 shs$17.12 million02/06/2024$30.79$30.71-0.26%$30.80$30.572,157 shs$16.89 million02/05/2024$30.74$30.79+0.16%$30.79$30.76875 shs$16.93 million02/02/2024$30.03$30.74+2.36%$30.78$30.422,109 shs$16.91 million02/01/2024$29.68$30.03+1.19%$30.07$29.873,806 shs$16.52 million01/31/2024$30.22$29.68-1.80%$29.93$29.653,852 shs$16.32 million01/30/2024$30.32$30.22-0.33%$30.40$30.222,391 shs$16.62 million01/29/2024$29.99$30.32+1.10%$30.32$30.072,058 shs$16.68 million01/26/2024$30.01$29.99-0.07%$30.10$29.985,109 shs$16.49 million Related Companies: DXD Stock Chart LGRO Stock Chart SIXO Stock Chart IFED Stock Chart SGLC Stock Chart DAX Stock Chart APRT Stock Chart LCG Stock Chart MMLG Stock Chart CHAU Stock Chart Receive TGRT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for T. Rowe Price Growth ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEARCA:TGRT) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsProtect Your Bank Account Before It’s Too LateWeiss RatingsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThey say it’s ‘unstoppable’ – How I made 43,509% Investing Daily Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding T. Rowe Price Growth ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.